Marmara University School of Medicine, Department of Physiology, Istanbul, Turkey.
Marmara University Vocational School of Health Related Services, Istanbul, Turkey.
J Physiol Pharmacol. 2019 Dec;70(6). doi: 10.26402/jpp.2019.6.03. Epub 2020 Feb 19.
Nesfatin-1, a recently discovered peptide, was shown to have anti-inflammatory effects. Acute pancreatitis (AP) is a life-threatening condition caused by various reasons. Although the etiology of AP is well-known, its pathogenesis is not clear. The aim of this study is to investigate the possible anti-inflammatory role of nesfatin-1 and its probable protective underlying mechanisms in an acute pancreatitis model. Caerulein was applied intraperitoneally to induce acute pancreatitis in Sprague-Dawley female rats. Nesfatin-1 was administered 5 minutes before the application of caerulein to determine its potential anti-inflammatory role on AP. Five minutes before nesfatin-1 injection, in order to investigate the underlying mechanism, oxytocin receptor antagonist (atosiban), melanocortin receptor antagonist (HS024), or ghrelin receptor antagonist (cortistatin) were administered. Five minutes after nesfatin-1 administration, two doses of caerulein were applied one hour apart. The rats were sacrified 12 hours after the first caerulein dose for serum and pancreatic tissue sampling. Microscopic damage scoring, malondialdehyde and glutathione levels, myeloperoxidase activity, luminol and lucigenin chemiluminescence levels in pancreatic tissue and amylase, lipase, trypsinogen-2 levels in serum were evaluated. Oxidative damage was decreased with nesfatin-1 treatment in the acute pancreatitis model (P < 0.05 - 0.001). The administration of HS024 reversed the effect of nesfatin-1, via increasing lipase, amylase, trypsinogen-2, malondialdehyde (MDA), myeloperoxidase (MPO) and lucigenin levels (P < 0.05 - 0.01). Atosiban pre-treatment elevated MPO activity, luminol and lucigenin chemiluminescence levels (P < 0.01 - 0.001) and cortistatin increased lucigenin and luminol chemiluminescence (P < 0.05 - 0.01). Although receptor antagonists reversed the effect of nesfatin-1 on related biochemical parameters, no significant difference was found in histological scoring. Our results indicated that nesfatin-1 had an anti-inflammatory effect on acute pancreatitis via mainly effecting melanocortin receptors.
Nesfatin-1 是一种新发现的肽,具有抗炎作用。急性胰腺炎 (AP) 是由多种原因引起的危及生命的疾病。虽然 AP 的病因众所周知,但发病机制尚不清楚。本研究旨在探讨 nesfatin-1 在急性胰腺炎模型中的可能抗炎作用及其潜在的保护机制。用 caerulein 腹腔内给药诱导 Sprague-Dawley 雌性大鼠急性胰腺炎。在给予 caerulein 前 5 分钟给予 nesfatin-1,以确定其对 AP 的潜在抗炎作用。在给予 nesfatin-1 前 5 分钟,为了探讨潜在机制,给予催产素受体拮抗剂 (atosiban)、黑色素皮质素受体拮抗剂 (HS024) 或生长抑素受体拮抗剂 (cortistatin)。给予 nesfatin-1 后 5 分钟,间隔 1 小时给予两次 caerulein 剂量。首次给予 caerulein 后 12 小时处死大鼠,取血清和胰腺组织样本。评估胰腺组织中的丙二醛和谷胱甘肽水平、髓过氧化物酶活性、鲁米诺和光解发光化学发光水平以及血清中的淀粉酶、脂肪酶、胰蛋白酶原-2 水平。nesfatin-1 治疗可减轻急性胰腺炎模型中的氧化损伤(P < 0.05-0.001)。给予 HS024 可通过增加脂肪酶、淀粉酶、胰蛋白酶原-2、丙二醛 (MDA)、髓过氧化物酶 (MPO) 和光解发光水平来逆转 nesfatin-1 的作用(P < 0.05-0.01)。阿托西班预处理可增加 MPO 活性、鲁米诺和光解发光化学发光水平(P < 0.01-0.001),而 cortistatin 可增加光解发光和鲁米诺化学发光(P < 0.05-0.01)。尽管受体拮抗剂逆转了 nesfatin-1 对相关生化参数的作用,但组织学评分无显著差异。我们的结果表明,nesfatin-1 通过主要作用于黑色素皮质素受体对急性胰腺炎具有抗炎作用。